ClearArc Capital’s Idexx Laboratories IDXX Stock Holding History

ClearArc Capital’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$239K	Sell	915 -399	-30%	-$105K	0.09%	253
2019 Q3	$357K	Buy	1,314 +32	+2%	+$8.9K	0.1%	231
2019 Q2	$353K	Sell	1,282 -169	-12%	-$41.6K	0.1%	232
2019 Q1	$324K	Sell	1,451 -29	-2%	-$5.99K	0.09%	262
2018 Q4	$275K	Sell	1,480 -757	-34%	-$155K	0.08%	266
2018 Q3	$558K	Buy	2,237 +3	+0.1%	+$728	0.07%	249
2018 Q2	$487K	Buy	2,234 +23	+1%	+$4.74K	0.07%	273
2018 Q1	$423K	Sell	2,211 -34	-2%	-$6.28K	0.06%	298
2017 Q4	$351K	Sell	2,245 -9	-0.4%	-$1.42K	0.05%	348
2017 Q3	$350K	Buy	2,254 +107	+5%	+$16.9K	0.05%	335
2017 Q2	$347K	Sell	2,147 -3	-0.1%	-$487	0.06%	325
2017 Q1	$332K	Buy	+2,150	New	+$296K	0.06%	330

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

ClearArc Capital's IDXX Position: Q4 2019 in Review

ClearArc Capital reduced its Idexx Laboratories (IDXX) stake by 30% in Q4 2019, selling an estimated $105K and leaving 915 shares worth $239K. The position accounts for 0.09% of the portfolio, ranked #253.

ClearArc Capital first reported a position in IDXX in Q1 2017 and has held it in 12 quarters since. The position peaked at $558K in Q3 2018. 761 funds tracked by Wall St. Rank hold IDXX as of Q4 2019.

ClearArc Capital held 915 shares of Idexx Laboratories worth $239K as of Q4 2019.
ClearArc Capital sold 399 Idexx Laboratories shares in Q4 2019, an estimated $105K.
Idexx Laboratories made up 0.09% of ClearArc Capital's portfolio in Q4 2019, its #253 holding.
ClearArc Capital first reported a position in Idexx Laboratories in Q1 2017 and has held it in 12 quarters since.
ClearArc Capital's Idexx Laboratories position peaked at $558K in Q3 2018.
761 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2019.

Based on ClearArc Capital's 13F filing for Q4 2019, filed 14 Feb 2020.